Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 23, 2015 09:00 ET | Source: Medical Marijuana Inc

Medical Marijuana Inc.’s New Real Scientific Hemp Oil™ Liquid Product Line Now Available for Import Into Brazilian Market

SAN DIEGO, Nov. 23, 2015 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (OTC Pink:MJNA) is pleased to announce the immediate release of its new line of Real Scientific Hemp Oil™ (RSHO™) products...
November 23, 2015 08:08 ET | Source: Future Market Insights

Pet Humanisation Trend Driving the Companion Animal Drug Market: Future Market Insights

VALLEY COTTAGE, N.Y., Nov. 23, 2015 (GLOBE NEWSWIRE) -- Future Market Insights (FMI) delivers key insights on the global companion animals drug market in its upcoming outlook titled, "Companion...
November 23, 2015 08:06 ET | Source: California Life Sciences Association

California Life Sciences Association (CLSA) Adds Leaders from Genentech, Sanford Burnham Prebys Medical Discovery Institute and OncoCyte to Board of Directors

SOUTH SAN FRANCISCO and SAN DIEGO, Nov. 23, 2015 (GLOBE NEWSWIRE) -- California Life Sciences Association (CLSA), today announced that its board of directors appointed three new members: William...
November 23, 2015 08:05 ET | Source: Peregrine Pharmaceuticals Inc.

Peregrine Pharmaceuticals to Participate in Two Upcoming Life Science Investor Conferences

TUSTIN, Calif., Nov. 23, 2015 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a biopharmaceutical company focused on developing therapeutics to stimulate the...
November 23, 2015 08:00 ET | Source: Chinook Therapeutics, Inc.

Aduro Biotech Receives Orphan Drug Designation in the European Union for CRS-207 for the Treatment of Mesothelioma

BERKELEY, Calif., Nov. 23, 2015 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq:ADRO) today announced that the European Medicines Agency (EMA) granted Orphan Drug Designation to CRS-207 for the...
November 23, 2015 08:00 ET | Source: Aceragen, Inc.

Idera to Collaborate With GSK to Identify 3rd Generation Antisense Molecules for Treatment of Renal Disease

CAMBRIDGE, Mass. and EXTON, Pa., Nov. 23, 2015 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a clinical-stage biopharmaceutical company developing toll-like receptor and RNA...
November 23, 2015 08:00 ET | Source: Merge Healthcare

Merge Healthcare and eviCore Healthcare Partner to Streamline Medical Imaging Prior Authorization Process for Providers and Payers

CHICAGO, Nov. 23, 2015 (GLOBE NEWSWIRE) -- Merge Healthcare, an IBM Company (NYSE:IBM), has entered into an agreement with eviCore healthcare that will automate and streamline the process providers...
November 23, 2015 07:00 ET | Source: Lumos Pharma, Inc.

NewLink Genetics Corporation Announces Clinical Data on Indoximod/Temozolomide Combination in Glioblastoma at Society for Neuro-Oncology Meeting

AMES, Iowa, Nov. 23, 2015 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK), a biopharmaceutical company at the forefront of discovering, developing and commercializing novel...
November 23, 2015 07:00 ET | Source: Bio Green Med Solution, Inc.

CYC065, Cyclacel’s Novel CDK2/9 Inhibitor, Prolongs Survival in MYCN-Addicted Neuroblastoma Models

BERKELEY HEIGHTS, N.J., Nov. 23, 2015 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company"), today announced the presentation of preclinical...
November 23, 2015 06:12 ET | Source: MarketResearchReports.Biz

Companies Venture into Global Biosimilar Market for Cost-effective Strategies: MarketResearchReports.Biz

Albany - New York, Nov. 23, 2015 (GLOBE NEWSWIRE) -- MarketResearchReports.biz has added a research report on the biotechnology industry to its database. The report, titled "Global & USA BioSimilar...